REED ELIZABETH E
CIK 1283303
Transactions on file
27
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 300 | $19.6K | -23.3% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 1,400 | $89.2K | -21.4% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 13,874 | $869.0K | -20.0% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 21,926 | $1.36M | -19.3% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Exer. | 37,500 | $579.8K | +223.9% | open → |
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 1,559 | $66.3K | +17.8% | open → |
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 5,226 | $217.5K | +20.3% | open → |
| 2026-04-15 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 7,215 | $302.5K | +19.4% | open → |
| 2026-04-15 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 37,500 | $1.54M | +21.9% | open → |
| 2026-04-15 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Exer. | 7,500 | $116.0K | +223.9% | open → |
| 2026-04-15 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Exer. | 20,000 | $359.2K | +178.8% | open → |
| 2026-04-15 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Exer. | 10,000 | $190.8K | +162.5% | open → |
| 2026-04-15 | 2026-04-13 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Grant | 14,000 | $0.00 | — | open → |
| 2025-01-23 | 2025-01-22 | TVTX Travere Therapeutics, Inc. | Officer SVP, GC & CORPORATE SECRETARY | Sale | 2,437 | $47.4K | +157.3% | open → |
| 2025-02-04 | 2025-02-03 | TVTX Travere Therapeutics, Inc. | Officer SVP, GC & CORPORATE SECRETARY | Sale | 8,951 | $177.1K | +153.2% | open → |
| 2025-02-04 | 2025-01-31 | TVTX Travere Therapeutics, Inc. | Officer SVP, GC & CORPORATE SECRETARY | Grant | 21,500 | $0.00 | — | open → |
| 2025-02-12 | 2025-02-10 | TVTX Travere Therapeutics, Inc. | Officer SVP, GC & CORPORATE SECRETARY | Exer. | 8,000 | — | — | open → |
| 2025-02-12 | 2025-02-12 | TVTX Travere Therapeutics, Inc. | Officer SVP, GC & CORPORATE SECRETARY | Sale | 8,000 | $188.2K | +112.8% | open → |
| 2025-05-05 | 2025-05-02 | TVTX Travere Therapeutics, Inc. | Officer Chief Legal Officer and GC | Exer. | 4,920 | — | — | open → |
| 2025-05-05 | 2025-05-05 | TVTX Travere Therapeutics, Inc. | Officer Chief Legal Officer and GC | Sale | 4,920 | $103.6K | +137.9% | open → |
| 2026-05-07 | 2026-05-06 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 2,076 | $91.2K | +13.9% | open → |
| 2026-05-07 | 2026-05-05 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 2,174 | $101.4K | +7.4% | open → |
| 2026-05-07 | 2026-05-04 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Exer. | 4,250 | $0.00 | — | open → |
| 2026-05-07 | 2026-05-04 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Sale | 20,000 | $900.0K | +11.3% | open → |
| 2026-05-07 | 2026-05-04 | TVTX Travere Therapeutics, Inc. | Chief Legal Officer and GC | Exer. | 20,000 | $359.2K | +178.8% | open → |
| 2025-09-24 | 2025-09-22 | TVTX Travere Therapeutics, Inc. | Officer Chief Legal Officer and GC | Exer. | 10,000 | $190.8K | +162.5% | open → |
| 2025-09-24 | 2025-09-22 | TVTX Travere Therapeutics, Inc. | Officer Chief Legal Officer and GC | Sale | 10,000 | $250.0K | +100.3% | open → |
